Formulation and evaluation of metoprolol tartrate transdermal drug patches
Authors
Article Information
Publication Timeline
- Published
Abstract
The objective of present study was to develop matrix type transdermal therapeutic systems of Metoprolol tartrate using various such as Sodium alginate and HPMC polymers as matrix formers. Results revealed that prepared patches showed good physical characteristics and no drug-polymer interaction was observed. The in vitro release study revealed that F3 formulation showed maximum release in 8 hrs. Formulation F3 was subjected for accelerated stability studies. The F3 formulation was found to be stable as there was no drastic change in the Physico-chemical properties of the patches, which was also confirmed by FTIR. Thus, conclusion can be made that stable transdermal patch of Metoprolol tartrate has been developed. F3 formulation showed highest cumulative percentage drug release of 93.97 % were obtained during in vitro drug release studies after 8 hrs. The predominant release mechanism of drug through the fabricated matrices was believed to be by diffusion mechanism. Based upon the in vitro dissolution data the F3 formulation was concluded as optimized formulation.
How to Cite
Anitha, M. R., Karthik, T., Vaishnavi, K., Manogna, K., & Vhishnavi, M. (2024). Formulation and evaluation of metoprolol tartrate transdermal drug patches. International Journal of Medical and All Body Health Research, 5(2), 22-25.
Anitha, Mary Rathna, et al. "Formulation and evaluation of metoprolol tartrate transdermal drug patches." International Journal of Medical and All Body Health Research, vol. 5, no. 2, 2024, pp. 22-25.
Anitha, M. R., Karthik, T., Vaishnavi, K., Manogna, K. and Vhishnavi, M. (2024) 'Formulation and evaluation of metoprolol tartrate transdermal drug patches', International Journal of Medical and All Body Health Research, 5(2), pp. 22-25.
Anitha MR, Karthik T, Vaishnavi K, Manogna K, Vhishnavi M. Formulation and evaluation of metoprolol tartrate transdermal drug patches. International Journal of Medical and All Body Health Research. 2024;5(2):22-25.
Similar Articles
- RP-HPLC Method Development and Validation for the Quantitative Determination of Ruxolitinib in Pure Form and Marketed Pharmaceutical Dosage Form Vol 5, Issue 2 (2024)
- Formulation and evaluation of gastroretentive floating microspheres of nimodipine Vol 5, Issue 2 (2024)
- A new analytical novel RP-HPLC method development and validation for the quantitative determination of Dasatinib in pure form and marketed pharmaceutical dosage form Vol 5, Issue 2 (2024)
- Effect of Vitamin E V/S Vitamin C application on wound healing in the gingival depigmentation procedure: A split-mouth clinical comparative study Vol 5, Issue 2 (2024)
- Ntoum: A major focus of malaria in Gabon's Estuary province Vol 5, Issue 2 (2024)
Find this Article on
Google Scholar Semantic Scholar OpenAlex ResearchGate BASEA newly published article may take a few days to appear on these services.